Karyopharm Therapeutics Inc (NASDAQ:KPTI) has a beta value of 0.23 and has seen 0.68 million shares traded in the recent trading session. The company, currently valued at $135.21M, closed the recent trade at $1.09 per share which meant it gained $0.08 on the day or 7.43% during that session. The KPTI stock price is -113.76% off its 52-week high price of $2.33 and 43.12% above the 52-week low of $0.62. The 3-month trading volume is 1.20 million shares.
Karyopharm Therapeutics Inc (NASDAQ:KPTI) trade information
Sporting 7.43% in the green today, the stock has traded in the green over the last five days, when the KPTI stock price touched $1.09 or saw a rise of 1.8%. Year-to-date, Karyopharm Therapeutics Inc shares have moved 25.43%, while the 5-day performance has seen it change 9.11%. Over the past 30 days, the shares of Karyopharm Therapeutics Inc (NASDAQ:KPTI) have changed -3.12%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Karyopharm Therapeutics Inc (KPTI) estimates and forecasts
Figures show that Karyopharm Therapeutics Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 39.50% over the past 6 months, with this year growth rate of 0.00%, compared to 14.30% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 16.79% over the past 5 years.
KPTI Dividends
Karyopharm Therapeutics Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
